Sec Form 4 Filing - FW Oak Hill Accretive Investors, L.P. @ Accretive Health, Inc. - 2011-11-30

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
FW Oak Hill Accretive Investors, L.P.
2. Issuer Name and Ticker or Trading Symbol
Accretive Health, Inc. [ AH]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
201 MAIN STREET, SUITE 3100
3. Date of Earliest Transaction (MM/DD/YY)
11/30/2011
(Street)
FORT WORTH, TX76102
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/30/2011 J( 1 ) 287,358 D 1,167,627 D ( 2 )
Common Stock 11/30/2011 J( 3 ) 8,184 A 95,356 D ( 3 )
Common Stock 11,076,964 D ( 4 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
FW Oak Hill Accretive Investors, L.P.
201 MAIN STREET
SUITE 3100
FORT WORTH, TX76102
X
GROUP VI 31 LLC
201 MAIN STREET
SUITE 3100
FORT WORTH, TX76102
X
CRANDALL J TAYLOR
2775 SAND HILL ROAD
SUITE 220
MENLO PARK, CA94025
X
Signatures
Kevin G. Levy, Vice President of Group VI 31, LLC, general partner of FW Oak Hill Accretive Investors, L.P. 12/02/2011
Signature of Reporting Person Date
Kevin G. Levy, Vice President of Group VI 31, LLC 12/02/2011
Signature of Reporting Person Date
Kevin G. Levy, as Attorney-in-Fact for J. Taylor Crandall 12/02/2011
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Distribution of shares to partners for no consideration.
( 2 )FW Oak Hill Accretive Investors, L.P. (the "Accretive Partnership") is the direct holder of these shares. Group VI 31, LLC ("Group VI 31") is the sole general partner of the Accretive Partnership. J. Taylor Crandall ("Crandall") is the sole member and President of Group VI 31 and a limited partner in the Accretive Partnership. Crandall and Group VI 31 disclaim beneficial ownership of the securities held by the Accretive Partnership except to the extent of their pecuniary interest therein.
( 3 )Receipt of shares in distribution from the Accretive Partnership for no consideration. These shares are now held directly by Crandall, for whom the distribution represented only a change in the form of his beneficial ownership.
( 4 )These shares are held directly by FW Oak Hill Accretive Healthcare Investors, L.P. (the "Healthcare Partnership"). Group VI 31 is the sole general partner of the Healthcare Partnership. Group VI 31 and Crandall disclaim beneficial ownership of the securities held by the Healthcare Partnership except to the extent of their pecuniary interest therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.